Aplicar la misma estrategia en pacientes implica buscar fármacos que bloqueen la vía molecular de KRAS en los mismos tres puntos. El equipo empleó una terapia triple, que combinaba un inhibidor de ...
Read moreA study led by the Pathogenesis of autoimmune neuronal disorders research group at IDIBAPS provides new evidence on the long-term evolution of patients with anti-NMDAR encephalitis in very serious sit...
Read moreThe results show that adenocarcinoma exhibits much more active and functional angiogenesis, with higher oxygen levels and less cell death, whereas squamous carcinoma shows poorer formation of blood ve...
Read moreProceeds to support clinical development of lead first-in-class program ONA-255 in breast cancer, toward clinical proof of concept, and advance ONA-389 in colorectal cancer
Read moreLa nueva herramienta, basada en tecnología CRISPR, permite identificar en pocas horas la bacteria Pseudomonas aeruginosa y uno de sus factores de virulencia más agresivos.
Read moreCTH120 es un tratamiento potencialmente modificador del síndrome X frágil, una enfermedad rara sin tratamiento específico aprobado a día de hoy que afecta gravemente a la cognición y la conducta....
Read moreJoan Martí: “Corporate culture is a critical factor in M&A and partnership processes.”
Read moreThe finding is the first direct observation of how the most abundant protein in the human body, which accounts for around a third of total protein mass, exists naturally inside living cells.
Read moreThe University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of €229.7 million raised by the companies in its ecosystem. Start-ups, spin-offs a...
Read moreNuestro compañero David Patrocinio participó del 7 al 10 de junio en el 15th International Colloids Conference, celebrado en Sitges, donde presentó dos pósteres científicos desarrollados en el ma...
Read moreEl estudio, liderado por el IEO y SOCIB, identifica el archipiélago balear como una zona de retención natural clave para la supervivencia de las larvas.
Read moreIQS and the company HIPRA Scientific are collaborating on the TECARN project, which aims to develop and validate advanced analytical methodologies for the analysis and characterization of mRNA intende...
Read more